Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.
from Business & Finance via Godstime David on Inoreader https://ift.tt/2SVrV3W
via
IFTTT
we need your feedback